Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
29,670
-
Shares change
-
+29,670
-
Total reported value, excl. options
-
$59,096
-
Value change
-
+$59,096
-
Number of buys
-
8
-
Price
-
$2
Significant Holders of IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) as of Q3 2024
8 filings reported holding IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK as of Q3 2024.
IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,670 shares
.
Largest 8 shareholders include JANE STREET GROUP, LLC (13,361 shares), HRT FINANCIAL LP (12,502 shares), BANK OF AMERICA CORP /DE/ (2,596 shares), BARCLAYS PLC (1,120 shares), MORGAN STANLEY (58 shares), WELLS FARGO & COMPANY/MN (29 shares), UBS Group AG (3 shares), and GROUP ONE TRADING LLC (1 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.